Abstract
The use of ex vivo machine perfusion for organ preservation has significantly improved solid organ transplantation outcomes. This modality of organ preservation has increased the donor pool and extended criteria for donor organs that would have previously been excluded from transplantation. Utilization of machine perfusion has protected donor organs from the injuries traditionally encountered by static cold storage, minimized rates of primary graft dysfunction, and even allowed for recovery of the function of marginal organs. Machine perfusion has also extended preservation periods well beyond what is considered acceptable after static cold storage for kidney, liver, lung, and hearts. The extended preservation time plus the growing use of ex vivo machine perfusion during organ procurement has introduced the potential for administering therapeutics during this period to improve organ quality and mitigate post-transplantation complications. The types of therapeutics that can be administered range from traditional pharmaceuticals to advanced therapeutics, such as gene and cell therapy. Here we review the history of organ preservation, post-transplantation complications amenable to therapeutic intervention, the types of ex vivo perfusion available, and therapeutic interventions that have been developed for administration during ex vivo perfusion.
This is a preview of subscription content, log in via an institution to check access.
References and Further Reading
Abt PL, Fisher CA, Singhal AK (2006) Donation after cardiac death in the US: history and use. J Am Coll Surg 203(2)
Aburawi MM, Fontan FM, Karimian N, Eymard C, Cronin S, Pendexter C et al (2019) Synthetic hemoglobin-based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion. Am J Transplant 19(10):2814–2824. https://doi.org/10.1111/ajt.15375
Ahmad K, Pluhacek JL, Brown AW (2022) Ex vivo lung perfusion: a review of current and future application in lung transplantation. Pulm Ther 8(2):149–165. https://doi.org/10.1007/s41030-022-00185-w
Aigner C, Slama A, Hötzenecker K, Scheed A, Urbanek B, Schmid W et al (2012) Clinical ex vivo lung perfusion—pushing the limits. Am J Transplant 12(7):1839–1847. https://doi.org/10.1111/j.1600-6143.2012.04027.x
Amberson WR, Mulder AG, Steggerda FR, Flexner J, Pankratz DS (1933) Mammalian life without red blood corpuscles. Science 78(2014):106–107. https://doi.org/10.1126/science.78.2014.106
Amberson WR, Jennings JJ, Rhode CM (1949) Clinical experience with hemoglobin-saline solutions. J Appl Physiol 1(7):469–489. https://doi.org/10.1152/jappl.1949.1.7.469
Aydin G, Okiye SE, Zincke H (1982) Successful 24-hour preservation of the ischemic canine kidney with Euro-Collins solution. J Urol 128(6):1401–1403. https://doi.org/10.1016/s0022-5347(17)53517-x
Bagul A, Hosgood SA, Kaushik M, Kay MD, Waller HL, Nicholson ML (2008) Experimental renal preservation by normothermic resuscitation perfusion with autologous blood. Br J Surg 95(1):111–118. https://doi.org/10.1002/bjs.5909
Barker CF, Markmann JF (2013) Historical overview of transplantation. Cold Spring Harb Perspect Med 3(4):a014977. https://doi.org/10.1101/cshperspect.a014977
Baumann M, Pan CR, Roos M, von Eynatten M, Sollinger D, Lutz J et al (2010) Pulsatile stress correlates with (micro-)albuminuria in renal transplant recipients. Transpl Int 23(3):292–298. https://doi.org/10.1111/j.1432-2277.2009.00981.x
Bishawi M, Roan J-N, Milano CA, Daneshmand MA, Schroder JN, Chiang Y et al (2019) A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy. Sci Rep 9(1):8029. https://doi.org/10.1038/s41598-019-43737-y
Bitargil M, Haddad O, Pham SM, Garg N, Jacob S, El-Sayed Ahmed MM et al (2022) Packing the donor heart: is SherpaPak cold preservation technique safer compared to ice cold storage. Clin Transpl 36(8):e14707. https://doi.org/10.1111/ctr.14707
Boettcher W, Merkle F, Weitkemper HH (2003a) History of extracorporeal circulation: the conceptional and developmental period. J Extra Corpor Technol 35(3):172–183
Boettcher W, Merkle F, Weitkemper HH (2003b) History of extracorporeal circulation: the invention and modification of blood pumps. J Extra Corpor Technol 35(3):184–191
Bonaccorsi-Riani E, Gillooly AR, Iesari S, Brüggenwirth IMA, Ferguson CM, Komuta M et al (2022) Delivering siRNA compounds during HOPE to modulate organ function: a proof-of-concept study in a rat liver transplant model. Transplantation 106(8):1565–1576. https://doi.org/10.1097/tp.0000000000004175
Boteon YL, Laing RW, Schlegel A, Wallace L, Smith A, Attard J et al (2019) The impact on the bioenergetic status and oxidative-mediated tissue injury of a combined protocol of hypothermic and normothermic machine perfusion using an acellular haemoglobin-based oxygen carrier: the cold-to-warm machine perfusion of the liver. PLoS One 14(10):e0224066. https://doi.org/10.1371/journal.pone.0224066
Brasile L, Henry N, Orlando G, Stubenitsky B (2019) Potentiating renal regeneration using mesenchymal stem cells. Transplantation 103(2):307–313. https://doi.org/10.1097/tp.0000000000002455
Cao H, Yang L, Hou B, Sun D, Lin L, Song H-L et al (2020) Heme oxygenase-1-modified bone marrow mesenchymal stem cells combined with normothermic machine perfusion to protect donation after circulatory death liver grafts. Stem Cell Res Ther 11(1):218. https://doi.org/10.1186/s13287-020-01736-1
Chen JY, Scerbo M, Kramer G (2009) A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics (Sao Paulo) 64(8):803–813. https://doi.org/10.1590/s1807-59322009000800016
Christie JD, Kotloff RM, Pochettino A, Arcasoy SM, Rosengard BR, Landis JR et al (2003) Clinical risk factors for primary graft failure following lung transplantation. Chest 124(4):1232–1241. https://doi.org/10.1378/chest.124.4.1232
Collins GM, Bravo-Shugarman M, Terasaki PI (1969) KIDNEY PRESERVATION FOR TRANSPORTATION: initial perfusion and 30 Hours’ ice storage. Lancet 294(7632):1219–1222. https://doi.org/10.1016/S0140-6736(69)90753-3
Elliott TR, Nicholson ML, Hosgood SA (2021) Normothermic kidney perfusion: an overview of protocols and strategies. Am J Transplant 21(4):1382–1390. https://doi.org/10.1111/ajt.16307
Famulski KS, Broderick G, Einecke G, Hay K, Cruz J, Sis B et al (2007) Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 7(11):2483–2495. https://doi.org/10.1111/j.1600-6143.2007.01980.x
Figueiredo C, Carvalho Oliveira M, Chen-Wacker C, Jansson K, Höffler K, Yuzefovych Y et al (2019) Immunoengineering of the vascular endothelium to silence MHC expression during normothermic ex vivo lung perfusion. Hum Gene Ther 30(4):485–496. https://doi.org/10.1089/hum.2018.117
Gage F, Leeser DB, Porterfield NK, Graybill JC, Gillern S, Hawksworth JS et al (2009) Room temperature pulsatile perfusion of renal allografts with Lifor compared with hypothermic machine pump solution. Transplant Proc 41(9):3571–3574. https://doi.org/10.1016/j.transproceed.2009.06.228
Garrido G, Dhillon GS (2019) Medical course and complications after lung transplantation. Springer, pp 279–288
Ghaidan H, Stenlo M, Niroomand A, Mittendorfer M, Hirdman G, Gvazava N et al (2022) Reduction of primary graft dysfunction using cytokine adsorption during organ preservation and after lung transplantation. Nat Commun 13(1):4173. https://doi.org/10.1038/s41467-022-31811-5
Goldaracena N, Spetzler VN, Echeverri J, Kaths JM, Cherepanov V, Persson R et al (2017) Inducing hepatitis C virus resistance after pig liver transplantation-a proof of concept of liver graft modification using warm ex vivo perfusion. Am J Transplant 17(4):970–978. https://doi.org/10.1111/ajt.14100
Guariento A, Doulamis IP, Duignan T, Kido T, Regan WL, Saeed MY et al (2020) Mitochondrial transplantation for myocardial protection in ex-situ–perfused hearts donated after circulatory death. J Heart Lung Transplant 39(11):1279–1288. https://doi.org/10.1016/j.healun.2020.06.023
Hamaoui K, Gowers S, Boutelle M, Cook TH, Hanna G, Darzi A et al (2016) Organ Pretreatment with Cytotopic endothelial localizing peptides to ameliorate microvascular thrombosis and perfusion deficits in ex vivo renal Hemoreperfusion models. Transplantation 100(12):e128–ee39. https://doi.org/10.1097/tp.0000000000001437
Hameed AM, Lu DB, Patrick E, Xu B, Hu M, Chew YV et al (2019) Brief normothermic machine perfusion rejuvenates discarded human kidneys. Transplant Direct 5(11):e502. https://doi.org/10.1097/txd.0000000000000944
Haque O, Raigani S, Rosales I, Carroll C, Coe TM, Baptista S et al (2021) Thrombolytic therapy during ex-vivo normothermic machine perfusion of human livers reduces peribiliary vascular plexus injury. Front Surg:8
Humphries AL Jr, Russell R, Stoddard LD, Moretz WH (1968) Successful five-day kidney preservation. Perfusion with hypothermic, diluted plasma. Investig Urol 5(6):609–618
Inci I, Arni S, Iskender I, Citak N, Rodriguez JM, Weisskopf M et al (2020) Functional, metabolic and morphologic results of ex vivo donor lung perfusion with a perfluorocarbon-based oxygen carrier nanoemulsion in a large animal transplantation model. Cell 9(11):2501. https://doi.org/10.3390/cells9112501
Iskender I, Arni S, Maeyashiki T, Citak N, Sauer M, Rodriguez JM et al (2021) Perfusate adsorption during ex vivo lung perfusion improves early post-transplant lung function. J Thorac Cardiovasc Surg 161(2):e109–ee21. https://doi.org/10.1016/j.jtcvs.2019.12.128
Jing L, Yao L, Zhao M, Peng L-p, Liu M (2018) Organ preservation: from the past to the future. Acta Pharmacol Sin 39(5):845–857. https://doi.org/10.1038/aps.2017.182
Jochmans I, Brat A, Davies L, Hofker HS, van de Leemkolk FEM, Leuvenink HGD et al (2020) Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial. Lancet 396(10263):1653–1662. https://doi.org/10.1016/s0140-6736(20)32411-9
Justiz Vaillant AA, Mohseni M (2022) Chronic transplantation rejection. StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2022, StatPearls Publishing LLC
Kay MD, Hosgood SA, Harper SJ, Bagul A, Waller HL, Rees D et al (2007) Static normothermic preservation of renal allografts using a novel nonphosphate buffered preservation solution. Transpl Int 20(1):88–92. https://doi.org/10.1111/j.1432-2277.2006.00390.x
Khan RS, Newsome PN (2019) A comparison of phenotypic and functional properties of mesenchymal stromal cells and multipotent adult progenitor cells. Front Immunol 10:1952. https://doi.org/10.3389/fimmu.2019.01952
Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D Jr, Hsich E et al (2019) The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match. J Heart Lung Transplant 38(10):1056–1066. https://doi.org/10.1016/j.healun.2019.08.004
Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M et al (2014) Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant 33(4):327–340. https://doi.org/10.1016/j.healun.2014.02.027
Ku TJY, Ribeiro RVP, Ferreira VH, Galasso M, Keshavjee S, Kumar D et al (2020) Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation. EBioMedicine 60:102994. https://doi.org/10.1016/j.ebiom.2020.102994
Laing RW, Stubblefield S, Wallace L, Roobrouck VD, Bhogal RH, Schlegel A et al (2020) The delivery of multipotent adult progenitor cells to extended criteria human donor livers using normothermic machine perfusion. Front Immunol:11. https://doi.org/10.3389/fimmu.2020.01226
Latchana N, Peck JR, Whitson B, Black SM (2014) Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature. J Thorac Dis 6(8):1143–1149. https://doi.org/10.3978/j.issn.2072-1439.2014.05.14
Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ et al (2016) Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 35(4):397–406
Luijmes SH, Verstegen MMA, Hoogduijn MJ, Seghers L, Minnee RC, Mahtab EAF et al (2022) The current status of stem cell-based therapies during ex vivo graft perfusion: an integrated review of four organs. Am J Transplant. https://doi.org/10.1111/ajt.17161
Machuca TN, Hsin MK, Ott HC, Chen M, Hwang DM, Cypel M et al (2013) Injury-specific ex vivo treatment of the donor lung: pulmonary thrombolysis followed by successful lung transplantation. Am J Respir Crit Care Med 188(7):878–880. https://doi.org/10.1164/rccm.201302-0368LE
Machuca TN, Cypel M, Yeung JC, Bonato R, Zamel R, Chen M et al (2015) Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion. Ann Surg 261(3):591–597. https://doi.org/10.1097/sla.0000000000000974
Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Van Raemdonck DE et al (2017) Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model. Stem Cell Res Ther 8(1):159. https://doi.org/10.1186/s13287-017-0603-5
Mendiola Pla M, Evans A, Lezberg P, Bowles DE (2022a) Ex vivo delivery of viral vectors by organ perfusion for cardiac transplantation gene therapy. In: Ishikawa K (ed) Cardiac gene therapy: methods and protocols. Springer US, New York, pp 249–259
Mendiola Pla M, Chiang Y, Roan J-N, E. Bowles D. (2022b) Gene therapy for cardiac transplantation. IntechOpen
Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC et al (2014) An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur Respir Soc
Mordant P, Nakajima D, Kalaf R, Iskender I, Maahs L, Behrens P et al (2016) Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation. J Heart Lung Transplant 35(10):1245–1254. https://doi.org/10.1016/j.healun.2016.04.017
Mühlberger I, Perco P, Fechete R, Mayer B, Oberbauer R (2009) Biomarkers in renal transplantation ischemia reperfusion injury. Transplantation 88(3 Suppl):S14–S19. https://doi.org/10.1097/TP.0b013e3181af65b5
Nakajima D, Watanabe Y, Ohsumi A, Pipkin M, Chen M, Mordant P et al (2019) Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant 38(11):1214–1223. https://doi.org/10.1016/j.healun.2019.07.006
Nghiem DD, Olson PR, Sureshkumar KK (2007) Significance of microvascular thrombosis in renal allografts: role of ex vivo thrombolytic therapy. Clin Transpl 21(2):172–176. https://doi.org/10.1111/j.1399-0012.2006.00616.x
Nilsson J, Jernryd V, Qin G, Paskevicius A, Metzsch C, Sjöberg T et al (2020) A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation. Nat Commun 11(1):2976. https://doi.org/10.1038/s41467-020-16782-9
Noris M, Remuzzi G (2010) Thrombotic microangiopathy after kidney transplantation. Am J Transplant 10(7):1517–1523. https://doi.org/10.1111/j.1600-6143.2010.03156.x
Okada Y, Kondo T (2009) Preservation solution for lung transplantation. Gen Thorac Cardiovasc Surg 57(12):635–639. https://doi.org/10.1007/s11748-009-0492-3
Okumura S, Uemura T, Zhao X, Masano Y, Tsuruyama T, Fujimoto Y et al (2017) Liver graft preservation using perfluorocarbon improves the outcomes of simulated donation after cardiac death liver transplantation in rats. Liver Transpl 23(9):1171–1185. https://doi.org/10.1002/lt.24806
Olschewski P, Gass P, Ariyakhagorn V, Jasse K, Hunold G, Menzel M et al (2010) The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers. Cryobiology 60(3):337–343. https://doi.org/10.1016/j.cryobiol.2010.03.005
Pallet N, Fougeray S, Beaune P, Legendre C, Thervet E, Anglicheau D (2009) Endoplasmic reticulum stress: an unrecognized actor in solid organ transplantation. Transplantation 88(5)
Patarroyo M, Simbaqueba C, Shrestha K, Starling RC, Smedira N, Tang WH et al (2012) Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. J Heart Lung Transplant 31(3):282–287. https://doi.org/10.1016/j.healun.2011.10.010
Patel K, Smith TB, Neil DAH, Thakker A, Tsuchiya Y, Higgs EB et al (2019) The effects of oxygenation on ex vivo kidneys undergoing hypothermic machine perfusion. Transplantation 103(2):314–322. https://doi.org/10.1097/tp.0000000000002542
Pilch NA, Bowman LJ, Taber DJ (2021) Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management. Pharmacotherapy 41(1):119–131. https://doi.org/10.1002/phar.2481
Pinezich M, Vunjak-Novakovic G (2019) Bioengineering approaches to organ preservation ex vivo. Exp Biol Med (Maywood) 244(8):630–645. https://doi.org/10.1177/1535370219834498
Pober JS, Jane-wit D, Qin L, Tellides G (2014) Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy. Arterioscler Thromb Vasc Biol 34(8):1609–1614. https://doi.org/10.1161/ATVBAHA.114.302818
Pool M, Eertman T, Sierra Parraga J, t Hart N, Roemeling-van Rhijn M, Eijken M et al (2019) Infusing mesenchymal stromal cells into porcine kidneys during normothermic machine perfusion: intact MSCs can be traced and localised to glomeruli. Int J Mol Sci 20(14). https://doi.org/10.3390/ijms20143607
Pool MBF, Vos J, Eijken M, van Pel M, Reinders MEJ, Ploeg RJ et al (2020) Treating Ischemically damaged porcine kidneys with human bone marrow- and adipose tissue-derived mesenchymal stromal cells during ex vivo normothermic machine perfusion. Stem Cells Dev 29(20):1320–1330. https://doi.org/10.1089/scd.2020.0024
Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A et al (2011) Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 30(7):735–742. https://doi.org/10.1016/j.healun.2011.01.712
Sato M, Hwang DM, Ohmori-Matsuda K, Chaparro C, Waddell TK, Singer LG et al (2012) Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation. J Heart Lung Transplant 31(4):354–363. https://doi.org/10.1016/j.healun.2011.12.015
Schraufnagel DP, Steffen RJ, Vargo PR, Attia T, Elgharably H, Hasan SM et al (2018) Devices for ex vivo heart and lung perfusion. Expert Rev Med Devices 15(3):183–191. https://doi.org/10.1080/17434440.2018.1430568
Schroder JN, D'Alessandro DA, Esmailian F, Boeve TJ, Tang PC, Liao KK et al (2019) Successful utilization of Extended Criteria Donor (ECD) hearts for transplantation - results of the OCS™ heart EXPAND trial to evaluate the effectiveness and safety of the OCS heart system to preserve and assess ECD hearts for transplantation. J Heart Lung Transplant
Shin B, Cowan DB, Emani SM, Del Nido PJ, McCully JD (2017) Mitochondrial transplantation in myocardial ischemia and reperfusion injury. Adv Exp Med Biol 982:595–619. https://doi.org/10.1007/978-3-319-55330-6_31
Spiess BD (2009) Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics. J Appl Physiol (1985) 106(4):1444–1452. https://doi.org/10.1152/japplphysiol.90995.2008
Starzl T, Fung J, Venkataramman R, Todo S, Demetris A, Jain A (1989) FK 506 for liver, kidney, and pancreas transplantation. Lancet 334(8670):1000–1004
Steen S, Liao Q, Wierup PN, Bolys R, Pierre L, Sjöberg T (2003) Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 76(1):244–52; discussion 52. https://doi.org/10.1016/s0003-4975(03)00191-7
Stone JP, Ball AL, Critchley WR, Major T, Edge RJ, Amin K et al (2016) Ex vivo normothermic perfusion induces donor-derived leukocyte mobilization and removal prior to renal transplantation. Kidney Int Rep 1(4):230–239. https://doi.org/10.1016/j.ekir.2016.07.009
Taylor MJ, Baicu SC (2010) Current state of hypothermic machine perfusion preservation of organs: the clinical perspective. Cryobiology 60(3 Suppl):S20–S35. https://doi.org/10.1016/j.cryobiol.2009.10.006
Thijssen MF, Moore CG, Xiaofei E, Wang X, Mandrekar P, Bozorgzadeh A et al (2017) Silencing p53 pathway of apoptosis alleviates ischemia-reperfusion injury (IRI) in the liver. J Am Coll Surg 225(4):e167
Thijssen MF, Brüggenwirth IMA, Gillooly A, Khvorova A, Kowalik TF, Martins PN (2019) Gene silencing with siRNA (RNA interference): a new therapeutic option during ex vivo machine liver perfusion preservation. Liver Transpl 25(1):140–151. https://doi.org/10.1002/lt.25383
Tingle SJ, Figueiredo RS, Moir JA, Goodfellow M, Talbot D, Wilson CH (2019) Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation. Cochrane Database Syst Rev 3(3):Cd011671. https://doi.org/10.1002/14651858.CD011671.pub2
Verstegen MMA, Mezzanotte L, Ridwan RY, Wang K, de Haan J, Schurink IJ et al (2020) First report on ex vivo delivery of paracrine active human mesenchymal stromal cells to liver grafts during machine perfusion. Transplantation 104(1):e5–e7. https://doi.org/10.1097/tp.0000000000002986
Weigt SS, DerHovanessian A, Wallace WD, Lynch JP III, Belperio JA (2013) Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation. Seminars in respiratory and critical care medicine:. Thieme Medical Publishers, pp 336–351
Weissenbacher A, Vrakas G, Nasralla D, Ceresa CDL (2019) The future of organ perfusion and re-conditioning. Transpl Int 32(6):586–597. https://doi.org/10.1111/tri.13441
Wood KJ, Goto R (2012) Mechanisms of rejection: current perspectives. Transplantation 93(1):1–10. https://doi.org/10.1097/TP.0b013e31823cab44
Wood KJ, Zaitsu M, Goto R (2013) Cell mediated rejection. Methods Mol Biol 1034:71–83. https://doi.org/10.1007/978-1-62703-493-7_3
Woodside KJ, Goldfarb DA, Rabets JC, Sanchez EQ, Lebovitz DJ, Schulak JA et al (2015) Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi-blinded prospective randomized trial. Clin Transpl 29(12):1173–1180. https://doi.org/10.1111/ctr.12647
Yang L, Cao H, Sun D, Lin L, Zheng WP, Shen ZY et al (2020) Normothermic machine perfusion combined with bone marrow mesenchymal stem cells improves the oxidative stress response and mitochondrial function in rat donation after circulatory death livers. Stem Cells Dev 29(13):835–852. https://doi.org/10.1089/scd.2019.0301
Yuzefovych Y, Valdivia E, Rong S, Hack F, Rother T, Schmitz J et al (2020) Genetic engineering of the kidney to permanently silence MHC transcripts during ex vivo organ perfusion. Front Immunol 11
Zulpaite R, Miknevicius P, Leber B, Strupas K, Stiegler P, Schemmer P (2021) Ex-vivo kidney machine perfusion: therapeutic potential. Front Med (Lausanne) 8:808719. https://doi.org/10.3389/fmed.2021.808719
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Mendiola Pla, M., Bowles, D.E. (2023). Delivery of Therapeutics to Solid Organs Using Ex Vivo Machine Perfusion. In: Hock, F.J., Gralinski, M.R., Pugsley, M.K. (eds) Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Springer, Cham. https://doi.org/10.1007/978-3-030-73317-9_102-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-73317-9_102-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-73317-9
Online ISBN: 978-3-030-73317-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences